Pres. Duterte Gets China’s Sinopharm COVID-19 Vaccince Jab
DUTERTE – President Rodrigo Roa Duterte spoke on his decision to get the Sinopharm COVID-19 developed by a Chinese company.
As part of the fight against the spread of COVID-19, most countries across the globe now are in the process of vaccinating a huge part of its populace. Nations and territories that are battling the pandemic are in the pursuit to achieve the “herd immunity”.
Several COVID-19 vaccines have arrived in the Philippines – Sinovac, AstraZeneca, Sinopharm, and Sputnik V. Many healthcare workers have already received the vaccine.
Aside from the healthcare workers, the senior citizens are also among the top priorities in the vaccination ladder. The authorities have different views with regards to the time that PH will achieve the herd immunity.
As for vaccine czar Carlito Galvez Jr., he is confident that more vaccines are arriving in the Philippines. Russia’s Sputnik V have already arrived.
Recently, Pres. Rodrigo Roa Duterte received his COVID-19 vaccine. He got Sinopharm which was developed by a Chinese company. Based on a report on ABS-CBN News, the Presidential Security Group (PSG) also received the same vaccine.
However, according to the report, Sinopharm was yet to be cleared by the World Health Organization (WHO) and the Philippine drug regulator for emergency use. It is only covered by a compassionate license for the security team of the Chief Executive.
As for Pres. Duterte, getting Sinopharm COVID-19 vaccine is upon the decision of his doctors. He also stressed that it is his life.
“Iyong itinurok sa akin… it’s the decision of my doctor. And all things said, this is my life,” the President said.
The President was previously called by some people to spearhead the vaccination to encourage the people not to be hesitant of the vaccines. Many also wanted it to be done publicly. Then, he stressed that he would rather give the dose to other people as he is already old.
Thank you for visiting Philnews.ph. You may express your thoughts and reactions below through the comment section. You may also follow us on Facebook, on Twitter, and subscribe to our YouTube channel Philnews Ph.